Cargando…

Hereditary Breast Cancer in Latvia: Mutation Analysis of the BRCA1 Gene

Detalles Bibliográficos
Autores principales:	Tihomirova, L., Csokay, B., Stengrevics, A., Sinicka, O., Kamerade, R., Olah, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 1999
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851386/ http://dx.doi.org/10.1155/1999/384636

Ejemplares similares

Germline BRCA2 and somatic P53 alterations in male breast cancer
por: Csokay, B, et al.
Publicado: (2000)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
por: Cipollini, G., et al.
Publicado: (1999)

BRCA1 Mutation Analysis in 27 Cypriot Families with High Risk of Hereditary Breast and Ovarian Cancer
por: Hadjisavvas, A., et al.
Publicado: (1999)

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer
por: Buleje, Jose, et al.
Publicado: (2017)

Hereditary Colorectal Cancer (CRC) Program in Latvia
por: Irmejs, Arvids, et al.
Publicado: (2003)

Clinical, Molecular and Geographical Features of Hereditary Breast/Ovarian Cancer in Latvia
por: Gardovskis, Andris, et al.
Publicado: (2005)

Spectrum of tumors in the families with Hereditary Breast Ovarian Cancer syndrome carrying germline mutations in BRCA1 and 2 genes
por: Budryk, M, et al.
Publicado: (2012)

Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer
por: Martínez-Ferrandis, JI, et al.
Publicado: (2000)

BRCA1 and BRCA2 Gene Mutations in Breast/Ovarian Cancer Patients from Central and Southern Italy
por: Ottini, Laura, et al.
Publicado: (1999)

Mutations of the BRCA1 and BRCA2 Genes in Danish Patients Diagnosed at Young Age with Multi-Centric or Bilateral Breast Cancer
por: Bergthorsson, J. T., et al.
Publicado: (1999)

Germline Mutations in BRCA1 and BRCA2 in Polish Families Predisposed to Breast and Ovary Cancers
por: Grzybowska, E., et al.
Publicado: (1999)

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family
por: Liao, Ying, et al.
Publicado: (2020)

Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
por: Blay, Pilar, et al.
Publicado: (2013)

Population screening for hereditary and familial cancer syndromes in Valka district of Latvia
por: Vanags, Andrejs, et al.
Publicado: (2010)

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer
por: Nicolussi, Arianna, et al.
Publicado: (2019)

Management of Breast Cancer in BRCA1/2 Mutation Carriers
por: Eeles, R. A., et al.
Publicado: (1999)

BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk
por: Kwiatkowski, Fabrice, et al.
Publicado: (2015)

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer
por: Garber, Haven R., et al.
Publicado: (2022)

National survey on clinical and genetic characteristics of patients with hereditary angioedema in Latvia
por: Kanepa, Adine, et al.
Publicado: (2023)

Reforming cap training in latvia: Nowhere to go but up
por: Bezborodovs, N.
Publicado: (2021)

Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in BRCA and in Other Susceptibility Genes
por: D’Elia, Giovanna, et al.
Publicado: (2022)

The Molecular Analysis of BRCA1 Mutations in the First Slovak Patients with Suspected Familial Breast Cancer
por: Kulcsar, L., et al.
Publicado: (1999)

BRCA1 Mutation Analysis in a Portuguese Population with Early-Onset Breast and/or Ovarian Cancer
por: Soares, Raquel, et al.
Publicado: (1999)

Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer
por: Vietri, Maria Teresa, et al.
Publicado: (2021)

A Novel Mutation-BRCA1 Associated Hereditary Haplotype of Intragenic Markers of BRCA1 Gene in a Family with History of Breast Cancer
por: Miresmaeili, Seyed Mohsen, et al.
Publicado: (2019)

BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome
por: Le, Trong-Nhan N., et al.
Publicado: (2022)

BRCA1 mutation analysis in breast and ovarian cancer families from Greece
por: Konstantopoulou, I, et al.
Publicado: (2000)

The contribution of LARGE genomic rearrangements of BRCA1 and BRCA2 gene mutations in breast and ovarian cancer families in a clinical cohort
por: Sawyer, S, et al.
Publicado: (2012)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

BRCA1 mutation in the Triple- Negative Breast Cancer Group
por: Maksimenko, Jelena, et al.
Publicado: (2012)

Impact of BRCA1 mutation on survival after early onset breast cancer
por: Huzarski, T, et al.
Publicado: (2012)

The impact of COVID-19 on young people’s mental health in latvia
por: Konstantinovs, N., et al.
Publicado: (2021)

Addressing Decision-Making Capacity in Application of Involuntary Treatment in Latvia: Case Law Analysis
por: Konstantinova, K., et al.
Publicado: (2023)

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile
por: Alvarez, Carolina, et al.
Publicado: (2017)

Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
por: Pouptsis, Athanasios, et al.
Publicado: (2020)

A Founder Mutation of the BRCA1-Gene in Western Sweden
por: Einbeigi, Zakaria, et al.
Publicado: (1999)

Latvia /
Publicado: (2001)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6sf4hqb9au5ms2l5c3h737bak2